From November 4 to 6, 2025, the World Drug Safety Congress Americas will take place at the Boston Convention and Exhibition Center in Boston. This event is a premier gathering for drug safety professionals and partners, offering a comprehensive platform for innovation, technology, and performance in the drug safety field.

The conference is expected to attract over 2,000 attendees, including 230+ speakers and 130+ sponsors and exhibitors. The event will feature 10 streams of content and hundreds of partnering meetings. The attendees will have the opportunity to hear from top thought leaders in the industry, explore innovative products and solutions that are revolutionizing the future of drug safety, and network with industry leaders from around the world.

The event spans the entire spectrum of drug safety, from early-stage safety assessments to post-market safety monitoring. It is where scientific innovation, regulatory frameworks, and industry collaboration intersect to drive meaningful advancements in patient safety and global health. The World Drug Safety Congress Americas is the defining event for the drug safety and pharmacovigilance space globally.

In addition to providing access to premium conference content, attendees will also have the opportunity to engage in facilitated meetings, interactive learning groups, networking through an app, and simply having fun. These activities are designed to facilitate timely comprehensive discussions on important safety topics, exchange ideas, build brand awareness, form friendships and partnerships, grow professional networks, explore future opportunities, and uncover new ones.

Several prominent speakers have been confirmed for this year's event. They include Han Ma from BeiGene USA Inc., Serban Ghiorghiu from AstraZeneca, Rania Mouchantaf from Health Canada, Peter Hjelmström from Uppsala Monitoring Centre, Jose Vega from Moderna Therapeutics, Yvonne Nanciu from Bayer Badrish Patel from Jazz Pharmaceuticals, Claudia Manzo from AbbVie, Mamiko Kasho from Eisai Felix Arellano from Roche Reema Mehta from Pfizer Narayan Nair from FDA.

The conference will cover a wide range of topics related to drug safety. These include quality assurance and compliance; AI & automation; patient centricity; global PV regulatory safety; risk management; next-gen tech & data analytics; real-world evidence & data analytics; compliance & quality assurance; safety in advanced therapies; vaccine safety; medtech.

If you are interested in sponsoring or exhibiting at this event or speaking at it as a thought leader in your field of expertise related to drug safety or pharmacovigilance – there are still opportunities available for you. Contact Semen Sen at semen.sen@terrapinn.com or Kaylee Nguyen at kaylee.nguyen@terrapinn.com for more information on how you can get involved.

Join us in Boston for what promises to be an exciting event that will shape the future of drug safety! Register today at www.worlddrugcongressamericas.com/register-now.